Improving treatment heart disease with new mathematical model

Improving treatment of heart disease with new mathematical model

11:32 PM, 15th February 2012
Improving treatment of heart disease with new mathematical model
New mathematical model for calculating calcium activity within the atrial heart cell.

NOTTINGHAM, UK: Beating of heart is the co-ordinated action of more than a billion muscle cells. Most of the time, only the muscle cells from the larger heart chambers contract and relax. But when the heart needs to work harder it relies on back-up from the atrial muscle cells deep within the smaller chambers (atria) of the heart. The health of these ‘high-performance’ atrial cells relies on specific concentrations of cellular calcium. Scientists at The University of Nottingham have produced a mathematical model of calcium activity within the atrial heart cell which will significantly improve chances of treating heart disease and stroke.

“This new model provides clinically relevant insights into the initiation and propagation of sub-cellular calcium signals. Thus, for the first time we can manipulate cellular properties throughout a whole atrial muscle cell in order to deduce which conditions give rise to abnormalities. This has the potential to point to new treatments for heart disease,” Dr Rudiger Thul, Lecturer, University of Nottingham. Most of the muscle cells surround the larger chambers of the heart, the ventricles. Under resting conditions, the ventricles are mainly responsible for contracting the heart. When blood needs to be pumped more quickly the smaller chambers of the heart contribute to the contraction. This is known as the atrial kick.

As we age or when something is wrong with our heart, the atrial muscle cells start to deteriorate. As a result we lose the support of the atrial kick. Atrial fibrillation constitutes the most common form of cardiac arrhythm, irregular heart beat. Several experimental studies have revealed that to trigger contraction in atrial muscle cells the calcium concentration follows an elaborate choreography which shows different concentration values in different parts of the cell. This is in contrast to ventricular cells where the calcium concentration is almost entirely uniform throughout the cell.

In order to fully understand atrial calcium dynamics we need to be able to monitor the atrial cell in its entirety. Unfortunately this is currently beyond even the best state-of-the-art experimental technology. Moreover, experimental manipulations of cells usually interfere with more than one cellular control mechanism making it harder to tease apart the contributions of different pathways. Therefore, developing cutting edge models of atrial cellular behaviour is crucial to our understanding.

“The strength of our model is that we can study the intracellular calcium concentration throughout the whole volume of the atrial muscle cell at the same time. This allows for a detailed exploration of the spatio-temporal calcium patterns associated with both healthy and pathological conditions. Moreover, we can selectively activate, deactivate, over or under express cellular properties and see how they shape the calcium patterns. Hence, we can deduce which conditions give rise to abnormalities and might lead to diseases such as atrial fibrillation and other cardiac pathologies, a fully three dimensional model of an atrial cell offers an ideal testing ground for new drugs,” said Dr Thul.

© University of Nottingham News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Solvay to sell 50 pc stake in Pipelife to Wienerberger

BRUSSELS, BELGIUM: Solvay and Wienerberger announced that they have signed a binding agreement for the sale of Solvay’s 50 per cent stake in Pip ...

Read more
Infineum to build salicylate manufacturing facility in Singapore

OXFORDSHIRE, UK: Infineum will commence construction of a new salicylate manufacturing facility at its Jurong site in Singapore in the first quarter o ...

Read more
EPA finalizes air toxic emissions standards for PVC

WASHINGTON, US: The US Environmental Protection Agency (EPA) issued strong final standards requiring facilities that produce polyvinyl chloride and ...

Read more
Foster Wheeler bags contract for CFB steam generator from Lunds Energi

ZUG, SWITZERLAND: Foster Wheeler AG announced that a subsidiary of its Global Power Group has been awarded a contract by Lunds Energi, a municipality- ...

Read more
Lonza plans joint venture for manufacturing API in South Africa

JOHANNESBURG, SOUTH AFRICA: South Africa will set up a $211 million joint venture with Lonza Group to manufacture the main chemicals used in HIV drugs ...

Read more
Fluor gets Joule Unlimited contract for biofuel demo facility

IRVING, US: Fluor Corporation announced that it was awarded an engineering, procurement and construction management (EPCm) contract by Joule Unlimited ...

Read more